Results 131 to 140 of about 869 (178)

Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions. [PDF]

open access: yesJ Allergy Clin Immunol, 2020
Valent P   +25 more
europepmc   +1 more source

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. [PDF]

open access: yesLeukemia, 2022
Khoury JD   +61 more
europepmc   +1 more source

Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis. [PDF]

open access: yesInt J Mol Sci, 2019
Dasilva-Freire N   +13 more
europepmc   +1 more source

A Multidisciplinary Diagnostic Approach Reveals a Higher Prevalence of Indolent Systemic Mastocytosis: 15-Years' Experience of the GISM Network. [PDF]

open access: yesCancers (Basel), 2021
Zanotti R   +8 more
europepmc   +1 more source

Using the Right Criteria for MCAS. [PDF]

open access: yesCurr Allergy Asthma Rep
Gulen T.
europepmc   +1 more source

Mast Cells as a Target-A Comprehensive Review of Recent Therapeutic Approaches. [PDF]

open access: yesCells, 2023
Baran J   +7 more
europepmc   +1 more source

Systemic mastocytosis: a clinical case report [PDF]

open access: yes, 2003
Aragão, A   +5 more
core  

Mastocitosis sistémica y resonancia magnética [PDF]

open access: yesAnales de Medicina Interna, 2001
García Erce, J. A.   +2 more
openaire   +3 more sources

Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis. [PDF]

open access: yesAllergy, 2012
Alvarez-Twose I   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy